Standing Committee for Clinical Affairs
Recommendations
It is the objective of EULAR to promote task forces aimed at elaborating recommendations in the
field of rheumatology. Such recommendations should strictly follow the published EULAR Standardized
Operating Procedures:
|
Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J,
Lloyd J, Ozen S, Da Silva JA, Emery P, Kalden JR, Kvien T, Matucci-Cerinic M, Smolen J;
EULAR.
EULAR standardised operating procedures for the elaboration, evaluation,
dissemination, and implementation of recommendations endorsed by the EULAR standing
committees.
Ann Rheum Dis. 2004 Sep; 63(9):1172-6
|
These recommendations can be split into three different categories:
- Recommendations for management of a specific musculoskeletal condition
- Recommendations for conducting clinical trials in a specific musculoskeletal condition
- Recommendations for considering the diagnosis of a specific musculoskeletal condition.
Recommendations for management
|
Recommendations for prevention and management of osteoporotic fractures Convenor: Willem Lems |
|
Recommendations for determining remission in rheumatoid arthritis (joint ACR-EULAR project) Convenor: Josef Smolen |
|
Recommendations for vaccination in patients with autoinflammatory rheumatic diseases Convenor: Marc Bijl |
|
Recommendations for the management of rheumatoid arthritis Convenor: Josef Smolen |
|
Recommendations for the prevention and treatment of osteoporosis associated with inflammatory musculoskeletal conditions Convenor: Anthony Woolf |
|
Implementation of recommendations on management of systemic glucocorticoid therapy in rheumatic disease with patients Convenor: Hans Bijlsma |
|
Recommendations for the managment of acute swollen joint, esp. knee (in collaboration with EFORT) Convenor: Désirée van der Heijde |
|
Points to consider for the management of cardiovascular risk in RA Convenor: Mike Nurmohamed |
|
Recommendations for the management of scleroderma (EUSTAR) Convenor: Marco Matucci-Cerinic |
|
Recommendations for the management of systemic lupus erythematosus (II): Neuropsychiatric, cardiovascular, joint and skin disease and general symptoms in SLE Convenor: Dimitrios Boumpas |
|
Recommendations for management of ankylosing spondylitis Convenor: Jürgen Braun |
Recommendations for conducting clinical trials
|
Points to consider in the design of clinical trials in systemic sclerosis Convenor: Daniel Furst |
|
Recommendations for monitoring systemic lupus erythematosus (SLE) patients in clinical practice and in observational studies Convenor: Stefano Bombardieri |
|
Recommendations for conducting clinical trials with corticosteroids Convenor: Hans Bijlsma |
Recommendations for diagnosis
|
Recommendations for terminology, diagnosis and management of calcium pyrophosphate crystal (CPPD) associated arthritis Convenor: Michael Doherty |
|
Recommendations for diagnosis of knee OA Convenor: Michael Doherty |
|
Points to consider for the diagnosis of systemic vasculitis (joint EULAR-ACR project) Convenor: Richard Watts |
RELATED INFORMATION
How to apply
An application (synopsis of the protocol specifying the category of recommendation [one of the 3 described in the main text], the exact title, the name of the convenor, the name of the clinical epidemiologist and the name of the experts) should be sent to the chairman of ESCCA at least 6 weeks prior to the upcoming Executive Committee meeting (in general mid-March, June at the congress and second-half of September).
Such application will be presented and discussed at a Executive Committee meeting, during which the decision to endorse it or not will be taken. A positive answer from the Executive Committee includes the fact that EULAR will financially support this initiative without any extra-financial support.